Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.53HKD
1.88 BHKD
10.53 BHKD
1.00 B
About GRAND PHARMACEUTICAL GROUP LTD
Sector
CEO
Chao Zhou
Headquarters
Hong Kong
Website
Employees (FY)
10.53 K
Founded
1995
ISIN
BMG210A71016
FIGI
BBG000C3NM14
Grand Pharmaceutical Group Ltd. engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 512 is 4.32 HKD — it has increased by 1.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GRAND PHARMACEUTICAL GROUP LTD stocks are traded under the ticker 512.
GRAND PHARMACEUTICAL GROUP LTD is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
512 stock is 3.58% volatile and has beta coefficient of 0.81. Check out the list of the most volatile stocks — is GRAND PHARMACEUTICAL GROUP LTD there?
Yes, you can track GRAND PHARMACEUTICAL GROUP LTD financials in yearly and quarterly reports right on TradingView.
512 stock has risen by 10.49% compared to the previous week, the month change is a 4.85% rise, over the last year GRAND PHARMACEUTICAL GROUP LTD has showed a 15.29% decrease.
512 net income for the last quarter is 850.64 M HKD, while the quarter before that showed 1.03 B HKD of net income which accounts for −17.36% change. Track more GRAND PHARMACEUTICAL GROUP LTD financial stats to get the full picture.
Today GRAND PHARMACEUTICAL GROUP LTD has the market capitalization of 14.92 B, it has increased by 0.50% over the last week.
Yes, 512 dividends are paid annually. The last dividend per share was 0.14 HKD. As of today, Dividend Yield (TTM)% is 0%. Tracking GRAND PHARMACEUTICAL GROUP LTD dividends might help you take more informed decisions.
GRAND PHARMACEUTICAL GROUP LTD dividend yield was 6.36% in 2023, and payout ratio reached 48.51%. The year before the numbers were 3.04% and 23.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 512 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAND PHARMACEUTICAL GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 10.53 K employees. See our rating of the largest employees — is GRAND PHARMACEUTICAL GROUP LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAND PHARMACEUTICAL GROUP LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAND PHARMACEUTICAL GROUP LTD stock shows the buy signal. See more of GRAND PHARMACEUTICAL GROUP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAND PHARMACEUTICAL GROUP LTD EBITDA is 3.11 B HKD, and current EBITDA margin is 29.02%. See more stats in GRAND PHARMACEUTICAL GROUP LTD financial statements.